Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Micro (56.4mn) 0 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Micro (56.2mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Micro (56.0mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Micro (55.9mn) 0 No activity — 50%+
Healthcare Services Micro (55.7mn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Micro (55.2mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Micro (55.2mn) -1–5 -< $100K -0–15% 15–50%
Healthcare Services Micro (55.0mn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Micro (54.9mn) 0 No activity — 50%+
Healthcare Services Micro (54.6mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Micro (54.6mn) 0 No activity — 15–50%
Healthcare Services Micro (54.1mn) -1–5 -< $100K -0–15% 15–50%
Healthcare Services Micro (54.0mn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Micro (53.9mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Micro (53.8mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Micro (53.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Micro (53.7mn) 0 No activity — 15–50%
Healthcare Services Micro (53.6mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Micro (53.5mn) 0 No activity — 15–50%
Healthcare Services Micro (52.9mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Micro (52.9mn) 0 No activity — 0–15%
Healthcare Services Micro (52.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Micro (52.0mn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Micro (52.0mn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Micro (51.8mn) 0 No activity — 50%+
Healthcare Services Micro (51.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Micro (51.6mn) 0 No activity — 15–50%
IN Haleos Labs Ltd (HALEOSLABS)
Pharmaceuticals & Medical Research Micro (51.6mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Micro (51.5mn) 0 No activity — 50%+
Healthcare Services Micro (51.5mn) 0 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Micro (51.3mn) 0 No activity — 50%+
Healthcare Services Micro (51.2mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Micro (50.9mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Micro (50.8mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Micro (50.8mn) 0 No activity — 0–15%
Healthcare Services Micro (50.1mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (50.0mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (49.9mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (49.2mn) 0 No activity — 15–50%
Healthcare Services Nano (49.2mn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (49.1mn) 0 No activity — 15–50%
Healthcare Services Nano (48.8mn) 1–5 < $100K 0–15% —
Healthcare Services Nano (48.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (48.7mn) 0 No activity — 0–15%
Healthcare Services Nano (48.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (47.8mn) 0 No activity — 0–15%
Healthcare Services Nano (47.0mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (46.8mn) 0 No activity — 0–15%
Healthcare Services Nano (46.7mn) 0 No activity — 15–50%
US CVRx Inc (CVRX)
Healthcare Services Nano (46.6mn) 0 < $100K 0–15% 15–50%
US Veru Inc (VERU)
Pharmaceuticals & Medical Research Nano (46.5mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (46.5mn) 0 No activity — 0–15%
Healthcare Services Nano (46.3mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (46.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (46.2mn) 1–5 < $100K 0–15% 50%+
Healthcare Services Nano (46.1mn) 1–5 $100K–$1M 0–15% 0–15%
FR Novacyt SA (ALNOV)
Pharmaceuticals & Medical Research Nano (45.9mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (45.8mn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Nano (45.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (45.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (45.0mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (45.0mn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (45.0mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (44.7mn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Nano (44.4mn) -1–5 -$100K–$1M -15–50% 50%+
Pharmaceuticals & Medical Research Nano (44.4mn) 0 No activity — 50%+
SE Doxa AB (DOXA)
Pharmaceuticals & Medical Research Nano (44.1mn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Nano (44.1mn) 0 No activity — 0–15%
Healthcare Services Nano (43.5mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (43.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (43.1mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (42.9mn) 0 -$100K–$1M -0–15% 15–50%
Healthcare Services Nano (42.9mn) 0 No activity — 15–50%
IN Albert David Ltd (ALBERTDAVD)
Pharmaceuticals & Medical Research Nano (42.8mn) 0 No activity — 50%+
Healthcare Services Nano (42.8mn) 0 No activity — 15–50%
Healthcare Services Nano (42.8mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (42.6mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (42.5mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (42.3mn) 0 No activity — 50%+
Healthcare Services Nano (42.1mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (41.7mn) -1–5 < $100K 0–15% 15–50%
SE Medivir AB (MVIR-B)
Pharmaceuticals & Medical Research Nano (41.7mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (41.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (40.9mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (40.8mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (40.7mn) 1–5 < $100K 0–15% 50%+
Healthcare Services Nano (40.7mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (40.3mn) 0 No activity — 0–15%
Healthcare Services Nano (39.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (39.5mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (39.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (39.3mn) 0 No activity — 0–15%
SE Q linea AB (QLINEA)
Healthcare Services Nano (39.0mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (38.9mn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Nano (38.9mn) 0 No activity — —
IN Nureca Ltd (NURECA)
Healthcare Services Nano (38.6mn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Nano (38.4mn) 0 No activity — 0–15%
Healthcare Services Nano (38.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (38.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (38.1mn) 1–5 < $100K 0–15% 15–50%